Common "Skyrizi" queries answered by top doctors | iCliniq

Skyrizi

Skyrizi is a brand under which a drug called Risankizumab is sold. It is a humanized monoclonal antibody incorporated for treating plaque psoriasis, psoriatic arthritis, and Crohn's disease by injecting subcutaneously.

Recently Answered Questions Recently Answered Questions

All the answers published in this website are written by verified medical doctors, therapists and health experts. The Content has been moderated by iCliniq medical review team before publication. Post your medical clarifications on iCliniq by choosing the right specialty and get them answered. Your medical queries will be answered 24/7 by top doctors from iCliniq.

I have psoriasis. Can Skyrizi be effective?

Query: Hi doctor,As a patient diagnosed with psoriasis and currently undergoing treatment with Skyrizi, I am immensely grateful for the advancements in medical science that have provided us with such therapeutic options. However, I would greatly appreciate your advice in addressing a few queries I have con...  Read Full »


Dr. S. Renjana

Answer: Hello, Welcome to icliniq.com. I understand your concern. How long has it been since you started on them? The response will depend on the severity of your psoriasis. It will definitely take around a month to start seeing differences. Also, try making lifestyle changes, which will aid in quick respon...  Read Full »

ask-doctor-img Ask a Doctor Online

* Your first query consult is free!

Search for a Health Issue



Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.